Moving back and forth among the bedside, the laboratory, and the policy arena has given me a wide view of health. As a ...

Prediction markets are the revenue layer most operators haven’t deployed yet. Built on event-based betting mechanics that sit ...

Welcome to the FinReg Monthly Update, a regular bulletin highlighting the latest developments in UK, EU and international financial ...

An analysis from the FLEX study showed that only patients in MammaPrint's highest risk category benefitted from the addition ...

Researchers at The University of Texas MD Anderson Cancer Center have discovered that an investigational epigenetic therapy ...

Preclinical study results suggest that targeting Hippo signaling may help address treatment resistance in acute myeloid ...

A novel epigenetic therapy has demonstrated activity against treatment-resistant acute myeloid leukaemia in preclinical ...

Researchers at The University of Texas MD Anderson Cancer Center have discovered a new way in which T cells attack acute ...

Dr. Monty Pal summarizes his practical first-line treatment algorithm for advanced renal cell carcinoma (RCC), highlighting ...

Bhavana “Tina” Bhatnagar, DO, reflects on AML’s transformation from few treatment options to targeted therapies and efforts to increase access to them. Acute myeloid leukemia (AML) has historically ...

A 1,563‑sample chromatin atlas reveals 16 epigenomic subgroups of AML, redefining disease classification, prognosis, and therapeutic vulnerabilities.

KOMET-007 tests ziftomenib with venetoclax and azacitidine in relapsed/refractory AML, selecting 600 mg to boost responses ...